The features of autonomic disorders and ischemic myocardial changes in patients with stable angina pectoris associated with nonalcoholic fatty liver disease

Authors

DOI:

https://doi.org/10.15587/2519-4798.2016.79872

Keywords:

ischemic heart disease, non-alcoholic fatty liver disease, autonomic imbalance, heart rhythm variability

Abstract

The aim of the work was in the establishing of the features of autonomic disorders and ischemic changes of myocardium in patients with stable angina pectoris, associated with non-alcoholic fatty liver disease.

Methods of research: the open prospective cohort study in parallel groups included 54 patients with IHD, among which were 30 patients with non-alcoholic fatty disease of the liver. All patients underwent the general clinical anthropometric examination, daily monitoring of ECG by Holter with determination of myocardium ischemia manifestations, study of the heart rhythm variability using the portable system Cardiosense K. (city Kharkov).

Conclusions: at the stable effort angina, associated with non-alcoholic fatty liver disease, the reliable decrease of SDNNi, RMSSD and pNN50 parameters in active and passive periods and more LF/HF values in both periods are observed that proves the ANS imbalance with predominance of the sympathetic link activity on the background of inhibition of parasympathetic influences. Patients with the stable angina pectoris with NAFLD are characterized with more expressed ischemic changes of myocardium such as prolongation of the general duration of ST segment depression during a day, depth of ST segment depression and the duration of maximal episode of ST segment depression and also the increase of the registration frequency of ventricle extrasystole comparing with patients without NAFLD

Author Biography

Любов Євгеніївна Міняйленко, Zaporizhzhia State Medical University Mayakovskogo ave., 26, Zaporizhzhya, Ukraine, 69035

Department of general practice – family medicine

References

  1. Gorbas, I. M., Sakalosh, V. Ju. et. al. (2010). Otsinka poshyrenosti ta kontrolyu faktoriv ryzyku sertsevo-sudynnykh zakhvoryuvanʹ sered naselennya ta likariv [Evaluation of prevalence and control of risk factors for cardiovascular disease in the population and doctors]. Medicines Ukraine, 1, 4–9.
  2. Terenda, N. O. (2015). Tendentsiyi ta prohnoz poshyrenosti stenokardiyi ta infarktu miokarda v Ukrayini [Trends and forecast prevalence of angina and myocardial infarction in Ukraine]. Journal of Social Hygiene and Health Organization Ukraine, 3 (65), 35–40.
  3. Mykhailovska, N. S., Oleinik, T. V., Mykhailovskiy, Y. M. (2015). Osoblyvosti zmin vehetatyvnoho statusu u patsiyentiv z ishemichnoyu khvoroboyu sertsya ta hipotyreozom u vzayemozvʺyazku z hormonamy hipofizarno-tyreoyidnoyi systemy [Features of the autonomic status changes in patients with coronary heart disease and hypothyroidism in conjunction with hormones pituitary-thyroid system]. Family medicine, 4 (60), 106–109.
  4. Anstee, Q. M., Targher, G., Day, C. P. (2013). Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nature Reviews Gastroenterology & Hepatology, 10 (6), 330–344. doi: 10.1038/nrgastro.2013.41
  5. Kosobyan, E. P., Smirnova, O. M. (2010). Sovremennye kontseptsyy patoheneza nealkoholʹnoy zhyrovoy bolezny pecheny [Modern concepts of nonalcoholic fatty liver disease pathogenesis]. Diabetes mellitus, 1, 55–64.
  6. Velichko, V. I., Kolotvina, L. I., Gur’ev, A. M. (2014). Ozhyrinnya y nealkoholʹna zhyrova khvoroba pechinky z pozytsiyi kardiovaskulyarnoho ryzyku v praktytsi simeynoho likarya [Obesity and nonalcoholic fatty liver disease with cardiovascular risk positions in the practice of family doctor]. Medicine of Ukraine’s transport, 1, 79–82.
  7. Kolesnykova, E. V. (2014). Sovremennyy patsyent s zabolevanyem pecheny i patolohyey serdechno-sosudystoy systemy: kakoy vybor sdelat? [Modern patient with liver disease and pathology of the cardiovascular system: Set some kind of Choice?]. Modern gastroenterology, 2 (76), 85–94.
  8. Fadeenko, H. D., Solomentseva, T. A., Dovhanyuk, Y. E. (2014). Rannye pryznaky ateroskleroza u bolʹnykh s nealkoholʹnoy zhyrovoy boleznʹyu pecheny [The early signs of atherosclerosis in patients with nonalcoholic fatty liver disease]. Modern gastroenterology, 4 (78), 32–37.
  9. Machado, M. V., Cortez-Pinto, H. (2013). Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal. Journal of Hepatology, 58 (5), 1007–1019. doi: 10.1016/j.jhep.2012.11.021
  10. Byrne, C. D., Targher, G. (2015). NAFLD: A multisystem disease. Journal of Hepatology, 62 (1), S47–S64. doi: 10.1016/j.jhep.2014.12.012
  11. Statsenko, M. E., Shilina, N. N., Turkina S. V. (2015). Osobennosti gepatokardial'nykh vzaimootnosheniy u patsiyentov s khronicheskoy serdechnoy nedostatochnost'yu i narusheniyami uglevodnogo obmena: vozmozhnosti dopolnitel'noy terapii [Features of hepato cardiac relationship in patients with chronic heart failure and impaired carbohydrate metabolism disorder: possible complementary therapy]. Regular editions of «RMJ», 21, 1293–1297.
  12. Newton, J. L. (2010). Systemic Symptoms in Non-Alcoholic Fatty Liver Disease. Digestive Diseases, 28 (1), 214–219. doi: 10.1159/000282089
  13. Siqueira, E. R. F., Pereira, L. M. M. B., Sanyal, A. J. (2015). Cardiovascular disease and NASH. Liver Research – Open Journal, 1 (2), 41–44. doi: 10.17140/lroj-1-107
  14. Ballestri, S. (2014). Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease. World Journal of Gastroenterology, 20 (7), 1724. doi: 10.3748/wjg.v20.i7.1724
  15. Sinner, M. F., Wang, N., Fox, C. S., Fontes, J. D., Rienstra, M., Magnani, J. W. et. al. (2013). Relation of Circulating Liver Transaminase Concentrations to Risk of New-Onset Atrial Fibrillation. The American Journal of Cardiology, 111 (2), 219–224. doi: 10.1016/j.amjcard.2012.09.021
  16. Robbins, J., Nelson, J. C., Rautaharju, P. M., Gottdiener, J. S. (2003). The association between the length of the QT interval and mortality in the cardiovascular health study. The American Journal of Medicine, 115 (9), 689–694. doi: 10.1016/j.amjmed.2003.07.014
  17. Bazilevich, A. Y. (2015). Non-alcoholic steatohepatitis as a new factor of developing ischaemic heart disease. ScienceRise, 10/3 (15), 171–175. doi: 10.15587/2313-8416.2015.52369
  18. Tyrykova, O. V., Kozlova, N. M., Eliseeva, S. M. (2015). Nealkoholʹnaya zhyrovaya boleznʹ pecheny y ee rolʹ v razvytyy serdechno-sosudystykh zabolevanyy [Nonalcoholic fatty liver disease and its role in the development of cardiovascular diseases]. Siberian Medical Journal, 1, 30–36.
  19. Liu, Y.-C., Hung, C.-S., Wu, Y.-W., Lee, Y.-C., Lin, Y.-H., Lin, C. et. al. (2013). Influence of Non-Alcoholic Fatty Liver Disease on Autonomic Changes Evaluated by the Time Domain, Frequency Domain, and Symbolic Dynamics of Heart Rate Variability. PLoS ONE, 8 (4), e61803. doi: 10.1371/journal.pone.0061803
  20. Dolzhenko, M. M., Mymrenko, S. M., Konoplyanik, L. I. (2013). Vplyv nealkoholʹnoyi zhyrovoyi khvoroby pechinky na stan vehetatyvnoyi nervovoyi systemy u khvorykh z postinfarktnoyu ishemichnoyu kardiomiopatiyeyu [The impact of nonalcoholic fatty liver disease on the state of the autonomic nervous system in patients with ischemic postinfarction cardiomyopathy]. Ukrainian Journal of Cardiology, 4, 132.

Published

2016-10-31

How to Cite

Міняйленко, Л. Є. (2016). The features of autonomic disorders and ischemic myocardial changes in patients with stable angina pectoris associated with nonalcoholic fatty liver disease. ScienceRise: Medical Science, (10 (6), 28–33. https://doi.org/10.15587/2519-4798.2016.79872

Issue

Section

Medical Science